HOME >> BIOLOGY >> NEWS
Collaboration advances potential therapy for autoimmune diseases

RICHLAND, Wash. - The Department of Energy's Pacific Northwest National Laboratory has launched a collaboration with two U.S. companies and Russian scientists to develop a more effective treatment for autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, which afflict nearly 50 million Americans. The collaboration represents the latest commercial venture between a former Russian weapons facility, a DOE national laboratory and U.S. industry under DOE's Initiatives for Proliferation Prevention program (IPP).

Through a Cooperative Research and Development Agreement, Advanced Biotherapy Inc. of Woodland Hills, Calif., and New Horizon Diagnostics Inc. of Columbia, Md., will hold nonexclusive licenses to inventions created by scientists at the Institute of Immunological Engineering of Moscow or by PNNL researchers through this program.

The Russian scientists have created unique humanized antibodies to gamma interferon, a protein that when overproduced triggers and exacerbates various autoimmune conditions. This work is a major step toward creating a much-improved treatment for certain autoimmune diseases. Until recently, most treatments employed antibodies derived from mice, which were effective but could be used only one or two times before the human body rejected them. Antibodies are proteins that bind to and disable foreign proteins, called antigens. With fully humanized antibodies, the human body potentially could accept them over longer periods of time, thus providing for long-term treatment.

The Russian research, coupled with a treatment method developed by Advanced Biotherapy, appears promising. During the past year, PNNL scientists have worked closely with the Russians to verify research results, monitor progress and identify and secure a viable commercial partner. PNNL is the technical lead for most biological and chemical-related projects conducted throughout several national laboratories for IPP.

"T
'"/>

Contact: Staci Maloof
staci.maloof@pnl.gov
509-372-6313
DOE/Pacific Northwest National Laboratory
3-Jun-2002


Page: 1 2 3

Related biology news :

1. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
2. Collaboration at EMSL produces innovative mass spectrometer
3. Collaboration to use proteomics to unravel mysteries of heart disease
4. Abgenix and Chiron enter Xenomouse Technology Collaboration, targets antibody products for autoimmune disease and cancer
5. University-Industry-Government Institute Will Study Pollution Control Chemistry In A Unique Virtual Collaboration
6. Very Fruitful Collaboration Between French And German Scientists Yields Unusual Insights Into The Structure Of Membrane Proteins
7. US-Cuban Scientific Collaborations Jeopardized By Travel Restrictions
8. Grant advances biochemical engineering laboratory
9. Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease
10. Undergraduate research experience advances education
11. UT Southwestern researchers cite recent advances in underlying causes of rare body-fat disorders

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/27/2018)... (PRWEB) , ... December 27, 2018 , ... ... 60 cervical discs for implantation at its new Boston facility, and is now ... have additional inventory to immediately expand market share against inferior ball and socket ...
(Date:12/20/2018)... PARK, N.C. (PRWEB) , ... December 20, 2018 ... ... been enhanced through upgraded processes and the completion of a new usability/observation room. ... with the goal of ensuring medical devices and drug delivery devices/combination products are ...
(Date:12/18/2018)... PHOENIX (PRWEB) , ... December 18, 2018 , ... ... Cell, has effectively incorporated artificial intelligence into client marketing. The technology has been ... six years, R3 Stem Cell has been working with clients nationwide on patient ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... January 07, 2019 , ... Today ... Noninvasix. This represents the second investment AngelMD has made into Noninvasix in the ... is developing a patient monitor to directly, accurately, and noninvasively measure brain oxygenation ...
(Date:1/4/2019)... ... January 02, 2019 , ... ... and cancer cells in blood, has been named as a partner in Medigen ... company developing cell therapies for cancer treatment, will use CellMax Life’s circulating tumor ...
(Date:12/18/2018)... ... December 17, 2018 , ... ABCT ... emerging biosciences ventures invited to participate in the annual program. Twelve ventures will ... plans and a professional network. All startups receive an entrepreneur coach, access to ...
(Date:12/13/2018)... , ... December 12, 2018 , ... ... life science software solutions, announces the Limfinity® ML (Machine Learning) addition for its ... machine learning models within Limfinity® solutions. In the module, trained models make predictions ...
Breaking Biology Technology:
Cached News: